Satellite Symposium: Working towards precision medicine approaches for CLL

Raúl Córdoba, Alessandra Tedeschi, Xose Antón Suárez Puente
Overview of current approaches for the management of patients with chronic lymphocytic leukemia (CLL) presented at the 7th ESH Translational Research Conference on Lymphoid Malignancies.

The Satellite Symposium, titled ‘Working towards precision medicine approaches for CLL’, provided insights into current therapeutic options for patients with chronic lymphocytic leukemia (CLL), including continuous vs fixed-duration treatments with targeted therapies such as BTK inhibitors (BTKi). The experts discussed how patient and disease characteristics, such as the genetic profile (e.g., del(17p), ukXE, bJ_#), inform treatment selection and sequencing. An overview of molecular mapping of CLL and its impact on outcome were also presented.

,l{Y/CZ

_Oúd OólCOV#

oY!vv~7[A~ c?g?Qc?&

8^_y 3saós 9qáVfX qIfT9f

Please login or register for full access

Register

Already registered?  Login